202223 Jun

SpotitEarly Raises $6.2 Million for Early Cancer Detection Tech Using Dogs

Summary

SpotitEarly, an Israeli medtech startup that specializes in the treatment of cancer, raised $6.2 million in a Seed funding round led by Hanaco Ventures. The company uses artificial intelligence (AI) to copy the smelling abilities of dogs in its tech, believe it or not.Founded in 2020 by four friends with experience in technology, digital health algorithmics, product development, and entrepreneurship Roi Ophir, Ohad Sharon, Udi Bobrovsky, and CEO Ariel Ben Dayan, SpotitEarly develops scent based multi-cancer early detection screening test, combining bio detectors taken from dogs olfactory capabilities together with proprietary AI stack.Everyone knows that dogs have a great sense of smell. As of today, the SpotitEarly tech can detect lung, prostate, breast, and colon cancer, but the company says it will be able to apply it to more cancers in the near future.That an Israeli company has developed this amazing new technology should not surprise anyone who has followed the daily news coming out of Israel Startup Nation. They proved that a drug delivery system based on lipid nanoparticles can utilize RNA to overcome resistance to both chemotherapy and immunotherapy in cancer treatments. They declared that the study opens a new path to a personalized and precisely targeted battle against cancer.And in March, both the Ben-Gurion University in Beer Sheva and the Weizmann Institute of Science announced new breakthroughs in cancer treatments.The statistics speak for themselves, Ben Dayan explained.

Source: Jewishbusinessnews

Funding

$6.2M
Amount
Jun 23 2022
Date
-
Investor
SpotitEarly
Company

Classifications

Companies